Lianos Georgios D, Christodoulou Dimitrios K, Katsanos Konstantinos H, Katsios Christos, Glantzounis Georgios K
Department of Surgery, School of Medicine, University of Ioannina, University Hospital of Ioannina, 451 10, Ioannina, Greece.
Department of Gastroenterology, School of Medicine, University of Ioannina, University Hospital of Ioannina, 451 10, Ioannina, Greece.
J Gastrointest Cancer. 2017 Jun;48(2):129-134. doi: 10.1007/s12029-017-9934-9.
Pancreatic resection for cancer represents a real challenge for every surgeon. Recent improvements in laparoscopic experience, minimally invasive surgical techniques and instruments make now the minimally invasive approach a real "triumph." There is no doubt that minimally invasive surgery has replaced with great success conventional surgery in many fields, including surgical oncology.
However, its progress in pancreatic resection for adenocarcinoma has been dramatically slow. Recent evidence supports the notion that minimally invasive distal pancreatectomy is safe and feasible and that is becoming the procedure of choice mainly for benign or low-grade malignant lesions in the distal pancreas. On the other side, minimally invasive pancreatoduodenectomy has not yet been widely accepted and there is enormous skepticism when applied for pancreatic head adenocarcinoma. In this review, we summarize the current evidence on the potential applications of minimally invasive surgical approaches for this aggressive, heterogeneous, and enigmatic type of cancer.
Moreover, the potential future applications of these approaches are discussed with the hope to improve the quality of life as well as the survival rates of pancreatic cancer patients.
胰腺癌的胰腺切除术对每位外科医生来说都是一项真正的挑战。腹腔镜经验、微创外科技术和器械的最新进展使微创方法如今成为一项真正的“胜利”。毫无疑问，微创手术已在包括外科肿瘤学在内的许多领域成功取代了传统手术。
然而，其在胰腺癌胰腺切除术中的进展极为缓慢。近期证据支持这样一种观点，即微创远端胰腺切除术是安全可行的，并且正成为主要用于远端胰腺良性或低级别恶性病变的首选术式。另一方面，微创胰十二指肠切除术尚未被广泛接受，应用于胰头腺癌时存在极大的质疑。在本综述中，我们总结了关于微创外科手术方法在这种侵袭性、异质性且神秘的癌症类型中的潜在应用的当前证据。
此外，还讨论了这些方法未来的潜在应用，以期改善胰腺癌患者的生活质量以及生存率。
